Success story:

"I'm adopted, so having this information makes me feel that I finally have an identity and that I’m the one controlling my health and my destiny."

-Terry,

software analyst

Press releases

Navigenics Raises $18 Million in Series C Financing

February 02, 2010

Procter and Gamble joins prominent group of Navigenics investors

More

Navigenics Names Vance Vanier, MD, to Serve as President and Chief Executive Officer

January 21, 2010

Dr. Vanier leads the company as it forges deeper relationships with physician groups and employer-sponsored health and wellness programs

More

Navigenics Receives State of New York Clinical Laboratory Permit

January 12, 2010

Navigenics becomes first personal genomics provider to be permitted by New York State Department of Health

More

An Open Letter to Nature

November 18, 2009

Navigenics and 23andMe respond to an Opinion piece by Craig Venter and others that appeared in Nature

More

Beth Israel Deaconess Medical Center and Navigenics Partner to Offer Pathology Residents Personalized Genetic Testing

October 21, 2009

Navigenics and BIDMC announce a collaboration to incorporate personal genomics into physician education

More

Navigenics Welcomes Michael Critelli to Board of Directors

September 17, 2009

Michael Critelli joins the Navigenics board

More

Silicon Valley Firms Partner to Promote Brain and Health Awareness

September 10, 2009

Navigenics and Posit Science join efforts for better health and stronger minds

More

Medcan Launches Most Comprehensive Personal Genomics Program in Canada

July 24, 2009

New program offers Canadians DNA insights to help prevent disease

More

David Agus, MD, Headlines with Celebrity Rock Stars as Geoffrey Beene Gives Back® and GQ Magazine Shine a Spotlight on Leading Scientists and the Promise of Medical Research

May 19, 2009

Navigenics co-founder David Agus, MD, is featured in the "Rock Stars of Science" public service campaign

More

Navigenics Names Jonathan Lord, MD to Serve as President and Chief Executive Officer

April 07, 2009

Navigenics announces Jack Lord from Humana, Inc., as new CEO

More

Navigenics Acquires Clinical Testing Facility

March 19, 2009

Navigenics announces the acquisition of the Affymetrix Clinical Services Laboratory

More

Navigenics Launches New Portal to Integrate Genomic Information into Medical Practices, Also Announces New Service Offering

January 28, 2009

Navigenics Annual Insight provides genetic risk assessments for ten common health conditions

More

National Physician Group MDVIP Partners with Navigenics to Provide Personal Genetic Tests for Preventive Medicine Practice

December 08, 2008

Navigenics and MDVIP announce a first-of-its-kind collaborative effort to integrate genomic-based preventive healthcare in physician offices

More

New Program to Help Physicians Understand Role of DNA-Based Preventive Medicine

November 04, 2008

Navigenics and the American College of Preventive Medicine (ACPM) announce a medical education program that explores genetic risk, screening and intervention

More

Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing

October 09, 2008

Navigenics teams with Scripps Translational Science Institute, Affymetrix and Microsoft on a groundbreaking health study

More

Navigenics launches Health Compass service

April 08, 2008

Flagship service kicks off with genetic health showcase and demonstration in New York City

More

Navigenics' genome analysis used in research trial on the impact of providing genetic risk assessments

April 08, 2008

Study, conducted by Mayo Clinic, began April 2008

More

Navigenics proposes standards for personal genomics services, coupled with prospective outcomes studies, to safeguard consumers

April 08, 2008

Company acts to "ensure the integrity of this critical step toward personalized health care"

More

Navigenics launches with pre-eminent team of advisors, collaborators and investors

November 06, 2007

Navigenics, Inc., launches officially, naming a team of advisors and investors from leading communities in science, medicine, technology and public policy who are supporting the company

More